Dyck, who is the Canada Research Chair in Molecular Medicine and heads up the Cardiovascular Research Center, says his team did not observe any detrimental functional effects on the hearts of mice with smaller hearts and thus would not expect any overt health effects in humans
This is where the conversation around GLP-1 medications becomes much more nuanced for active menopausal women
As mentioned, DPP-4 inhibitors increase the concentration of endogenous GLP-1, leading to increased insulin secretion, decreased glucagon secretion, and decreased HbA1c in patients with T2DM
Injection site reactions occur in approximately 5 to 10% of users
This legal battle underscores ongoing supply chain issues with popular GLP-1 medications like Zepbound, Mounjaro, and Novo Nordisks Wegovy, all of which have seen surging demand
Dont adjust on your ownbring any changes or concerns to your prescriber